Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study

作者：Jin−Ji Yang, Yu Mu, Zhehai Wang, Jianchun Duan, Tao Zhang, Lin Wu, Hua Zhong, Jun Zhao, Yu Yao, Ping Wang, Xiaoling Li, Runxiang Yang, Xuhong Min, Dongqing Lv, Haipeng Xu, Zhenming Fu, Bo Shen, Longhua Sun, Changli Wang, Jianya Zhou, Ruilian Xu, Huiwen Ma, Yanqiu Zhao, He-Peng Shi, Pei-Long Zhang, Wei-Zhe Xue, Di Han, Yi Zheng, Yi-Long Wu · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.11.008 · 被引用次数：2 · 研究领域：Lung Cancer Treatments and Mutations、Chronic Myeloid Leukemia Treatments、Colorectal Cancer Treatments and Studies